Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
When the arteries supplying blood to the stomach and liver swell and burst, it is an emergency in which 50% of patients die before reaching the hospital. This "silent killer" situation, know...
Read Full NewsAnjali Vaidya, MD, explains why echocardiography should inform right heart catheterization interpretation in pulmonary hypertension at CHEST 2026.
Samantha Pettigrew, MD, reviews HI-PEITHO, PRAGUE-26, and PEERLESS and how they shape intervention choices in intermediate-risk PE at CHEST 2026.
Updated data from Breakfree-2 study showed that treatment with a single zola-cel infusion achieved NEDA-3 in highly active relapsing multiple sclerosis and led to mostly stable disability in progressive multiple sclerosis.
Phase 3 data show the oral BTK inhibitor reduced annualized relapse rate by 35.2% and 31.2% vs teriflunomide, with no liver safety signal or Hy's Law cases.
At a NeurologyLive and Targeted Oncology Clinical Forum in Houston, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how incidental diagnosis and limited awareness of systemic therapy continue to delay care for patients with NF1-associated plexiform neurofibromas.
A secondary analysis of the BRIDGE-TNK trial found tenecteplase before thrombectomy improved functional outcomes in cardioembolic but not atherosclerotic stroke.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent advances in gene therapies.
1.
No increased risk of childhood cancer near UK nuclear sites, study finds
2.
Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?
3.
EMA Backs Breast Cancer SERD After FDA No Vote
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.
1.
Rehabilitation of Physical Endurance Following Prolonged Cytopenic States
2.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
3.
Emerging Therapies Using Synthetic Hematopoietic Support Systems
4.
Fatigue Rehabilitation in Chronic Anemia: Mechanisms, Clinical Strategies, and Emerging Therapeutics
5.
Advanced Methods in Oncology in Daily Practice
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Navigating the Complexities of Ph Negative ALL - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
3.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
4.
Common Cancer Myths Debunked
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge